ArticleCEN case reports2026
Pediatric anti-GBM crescentic glomerulonephritis: partial renal recovery following plasmapheresis and mycophenolate mofetil.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anti-glomerular basement membrane (anti-GBM) glomerulonephritis is a rare cause of rapidly progressive glomerulonephritis in children. The disease is characterized by the formation of antibodies against the glomerular basement membrane, leading to diffuse glomerular injury and rapid deterioration of renal function if not diagnosed and treated promptly. We report the case of a 14 year-old girl who was admitted with acute-onset edema and hypertension. Initial investigations revealed hematuria, proteinuria, hypoalbuminemia, progressive renal impairment, and positive anti-GBM antibodies. Kidney biopsy confirmed the diagnosis, demonstrating diffuse crescentic glomerulonephritis with linear IgG deposition along the glomerular basement membrane. The patient was treated with high-dose corticosteroids, plasmapheresis, and mycophenolate mofetil. After three months of treatment, both clinical and laboratory parameters improved, with partial recovery of renal function. This case highlights the importance of early recognition and prompt treatment of pediatric anti-GBM disease and suggests that an MMF-containing combination regimen may be a feasible alternative to cyclophosphamide-based therapy in selected patients.
Indexed as
Identifiers
42850491What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.